Exploring Leptin Antagonism in Ophthalmic Cell Models

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Scolaro, Laura ^a   Parrino, Cristina ^a   Coroniti, Roberta ^a   Otvos Jr , Laszlo ^b   Surmacz, Eva ^a  

^a TEMPLE UNIVERSITY   (United States)

^b Temple University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLO ACA; CYCLOOXYGENASE 2; HORMONE RECEPTOR BLOCKING AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEPTIN; LEPTIN RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CELL STIMULATION; CELL STRAIN BCE; CELL STRAIN RF6A; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORNEA CELL; COW; ENDOTHELIUM CELL; GENE EXPRESSION; HAPLORHINI; INFLAMMATION; MITOGENESIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETINA CELL; SIGNAL TRANSDUCTION;

ANIMALS; CATTLE; CORNEA; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HAPLORHINI; INTRACELLULAR SPACE; LEPTIN; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDOMIMETICS; RECEPTORS, LEPTIN; RETINA; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84884848435     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076437     Document Type: Article

References (58)

1. Chang JH, Garg NK, Lunde E, Han KY, Jain S, et al. (2012) Corneal neovascularization: an anti-VEGF therapy review. Surv Ophthalmol 57: 415-429. doi:10.1016/j.survophthal.2012.01.007. PubMed: 22898649.
2. Lee P, Wang CC, Adamis AP, (1998) Ocular neovascularization: an epidemiologic review. Surv Ophthalmol 43: 245-269. doi:10.1016/S0039-6257(98)00035-6. PubMed: 9862312.
3. Qazi Y, Maddula S, Ambati BK, (2009) Mediators of ocular angiogenesis. J Genet 88: 495-515. doi:10.1007/s12041-009-0068-0. PubMed: 20090210.
4. Tang J, Kern TS, (2011) Inflammation in diabetic retinopathy. Prog Retin Eye Res 30: 343-358. doi:10.1016/j.preteyeres.2011.05.002. PubMed: 21635964.
5. Misra GP, Imai H, Singh RJ, Lowe TL, Gardner TW, (2010) Diabetic retinopathy and diabetic macular edema. In: Sauders WB, eds. Edinburgh: Retinal Pharmacology: Elsevir. pp. 133-136.
6. Praidou A, Androudi S, Brazitikos P, Karakiulakis G, Papakonstantinou E, et al. (2010) Angiogenic growth factors and their inhibitors in diabetic retinopathy. Curr. Diabetes Rev 6: 304-312. doi:10.2174/157339910793360815.
7. Willard AL, Herman IM, (2012) Vascular complications and diabetes: current therapies and future challenges. J Ophthalmol, 2012(2012): 209538. PubMed: 22272370.
8. Stewart MW, (2012) The expanding role of vascular endothelial growth factor inhibitors in ophthalmology. Mayo Clin Proc 87: 77-88. doi:10.1016/j.mayocp.2012.08.003. PubMed: 22212972.
9. Truong A, Wong TY, Khachigian LM, (2011) Emerging therapeutic approaches in the management of retinal angiogenesis and edema. J Mol Med (Berl) 89: 343-361. doi:10.1007/s00109-010-0709-z. PubMed: 21170513.
10. Friedman JM, Halaas JL, (1998) Leptin and the regulation of body weight in mammals. Nature 395: 763-770. doi:10.1038/27376. PubMed: 9796811.
11. Wauters M, Considine RV, Van Gaal LF, (2000) Human leptin: from an adipocyte hormone to an endocrine mediator. Eur J Endocrinol 143: 293-311. doi:10.1530/eje.0.1430293. PubMed: 11022169.
12. Sweeney G, (2010) Cardiovascular effects of leptin. Nat. Rev Cardiol 7: 22-29. doi:10.1038/nrcardio.2009.224.
13. Zhang F, Chen Y, Heiman M, Dimarchi R, (2005) Leptin: structure, function and biology. Vitam Horm 71: 345-372. doi:10.1016/S0083-6729(05)71012-8. PubMed: 16112274.
14. Garofalo C, Surmacz E, (2006) Leptin and cancer. J Cell Physiol 207: 12-22. doi:10.1002/jcp.20472. PubMed: 16110483.
15. Scolaro L, Cassone M, Kolaczynski JW, Otvos L Jr, Surmacz E, (2010) Leptin-based therapeutics. Expert. Rev Endocrinol Metab 5: 875-889. doi:10.1586/eem.10.61.
16. Margetic S, Gazzola C, Pegg GG, Hill RA, (2002) Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 26: 1407-1433. doi:10.1038/sj.ijo.0802142. PubMed: 12439643.
17. Anagnostoulis S, Karayiannakis AJ, Lambropoulou M, Efthimiadou A, Polychronidis A, et al. (2008) Human leptin induces angiogenesis in vivo. Cytokine 42: 353-357. doi:10.1016/j.cyto.2008.03.009. PubMed: 18448353.
18. Bouloumié A, Drexler HC, Lafontan M, Busse R, (1998) Leptin, the product of Ob gene, promotes angiogenesis. Circ Res 83: 1059-1066. doi:10.1161/01.RES.83.10.1059. PubMed: 9815153.
19. Park HY, Kwon HM, Lim HJ, Hong BK, Lee JY, et al. (2001) Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med 33: 95-102. doi:10.1038/emm.2001.17. PubMed: 11460888.
20. Sierra-Honigmann MR, Nath AK, Murakami C, García-Cardeña G, Papapetropoulos A, et al. (1998) Biological action of leptin as an angiogenic factor. Science 281: 1683-1686. doi:10.1126/science.281.5383.1683. PubMed: 9733517.
21. Garonna E, Botham KM, Birdsey GM, Randi AM, Gonzalez-Perez RR, et al. (2011) Vascular endothelial growth factor receptor-2 couples cyclo-oxygenase-2 with pro-angiogenic actions of leptin on human endothelial cells. PLOS ONE 6: e18823. doi:10.1371/journal.pone.0018823. PubMed: 21533119.
22. Ferla R, Bonomi M, Otvos L Jr., Surmacz E, (2011) Glioblastoma-derived leptin induces tube formation and growth of endothelial cells: comparison with VEGF effects. BMC Cancer 11: 303. doi:10.1186/1471-2407-11-303. PubMed: 21771332.
23. Cao R, Brakenhielm E, Wahlestedt C, Thyberg J, Cao Y, (2001) Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci U S A 98: 6390-6395. doi:10.1073/pnas.101564798. PubMed: 11344271.
24. Suganami E, Takagi H, Ohashi H, Suzuma K, Suzuma I, et al. (2004) Leptin stimulates ischemia-induced retinal neovascularization: possible role of vascular endothelial growth factor expressed in retinal endothelial cells. Diabetes 53: 2443-2448. doi:10.2337/diabetes.53.9.2443. PubMed: 15331557.
25. Bjørbaek C, Buchholz RM, Davis SM, Bates SH, Pierroz DD, et al. (2001) Divergent roles of SHP-2 in ERK activation by leptin receptors. J Biol Chem 276: 4747-4755. doi:10.1074/jbc.M007439200. PubMed: 11085989.
26. Villanueva EC, Myers MG Jr., (2008) Leptin receptor signaling and the regulation of mammalian physiology. Int J Obes (Lond) 32 (Suppl 7):: S8-12. doi:10.1038/ijo.2008.82. PubMed: 19136996.
27. Sweeney G, (2002) Leptin signalling. Cell Signal 14: 655-663. doi:10.1016/S0898-6568(02)00006-2. PubMed: 12020765.
28. Zabeau L, Lavens D, Peelman F, Eyckerman S, Vandekerckhove J, et al. (2003) The ins and outs of leptin receptor activation. FEBS Lett 546: 45-50. doi:10.1016/S0014-5793(03)00440-X. PubMed: 12829235.
29. Basak S, Duttaroy AK, (2012) Leptin induces tube formation in first-trimester extravillous trophoblast cells. Eur J Obstet Gynecol Reprod Biol 164: 24-29. doi:10.1016/j.ejogrb.2012.05.033. PubMed: 22717511.
30. Sun G, Su G, Zhang M, Zeng Q, Shi Q, (2011) Effect of tetrandrine on the expression of leptin (LP) and vascular endothelial growth factor (VEGF) in corneal neovascularization of rats. Scient Res Essays 6: 5008-5013.
31. Gariano RF, Nath AK, D'Amico DJ, Lee T, Sierra-Honigmann MR, (2000) Elevation of vitreous leptin in diabetic retinopathy and retinal detachment. Invest Ophthalmol Vis Sci 41: 3576-3581. PubMed: 11006255.
32. Maberley D, Cui JZ, Matsubara JA, (2006) Vitreous leptin levels in retinal disease. Eye (Lond) 20: 801-804. doi:10.1038/sj.eye.6702011. PubMed: 16052255.
33. Hernández C, Lecube A, Castellanos JM, Segura RM, Garat M, et al. (2004) Intravitreous leptin concentrations in patients with proliferative diabetic retinopathy. Retina 24: 30-35. doi:10.1097/00006982-200402000-00005. PubMed: 15076941.
34. Beccari S, Kovalszky I, Wade JD, Otvos L, Surmacz E, (2013) Designer peptide antagonist of the leptin receptor with peripheral antineoplastic activity. Peptides (. (2013)) PubMed: 23567149.
35. Otvos L Jr, Kovalszky I, Scolaro L, Sztodola A, Olah J, et al. (2011) Peptide-based leptin receptor antagonists for cancer treatment and appetite regulation. Biopolymers 96: 117-125. doi:10.1002/bip.21377. PubMed: 20564005.
36. Kovalszky I, Surmacz E, Scolaro L, Cassone M, Ferla R, et al. (2010) Leptin-based glycopeptide induces weight loss and simultaneously restores fertility in animal models. Diabetes Obes Metab 12: 393-402. doi:10.1111/j.1463-1326.2009.01170.x. PubMed: 20415687.
37. Otvos L Jr., Shao WH, Vanniasinghe AS, Amon MA, Holub MC, et al. (2011) Toward understanding the role of leptin and leptin receptor antagonism in preclinical models of rheumatoid arthritis. Peptides 32: 1567-1574. doi:10.1016/j.peptides.2011.06.015. PubMed: 21723351.
38. Otvos L Jr., Cassone M, Terrasi M, Cascio S, Mateo GD, et al. (2009) Agonists and partial antagonists acting on the leptin--leptin receptor interface. Adv Exp Med Biol 611: 497-498. doi:10.1007/978-0-387-73657-0_215. PubMed: 19400282.
39. Otvos L Jr., Kovalszky I, Riolfi M, Ferla R, Olah J, et al. (2011) Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer. Eur J Cancer 47: 1578-1584. doi:10.1016/j.ejca.2011.01.018. PubMed: 21353530.
40. Otvos L Jr., Surmacz E, (2011) Targeting the leptin receptor: a potential new mode of treatment for breast cancer. Expert Rev Anticancer Ther 11: 1147-1150. doi:10.1586/era.11.109. PubMed: 21916566.
41. Garofalo C, Sisci D, Surmacz E, (2004) Leptin interferes with the effects of the antiestrogen ICI 182,780 in MCF-7 breast cancer cells. Clin Cancer Res 10: 6466-6475. doi:10.1158/1078-0432.CCR-04-0203. PubMed: 15475434.
42. Cascio S, Bartella V, Auriemma A, Johannes GJ, Russo A, et al. (2008) Mechanism of leptin expression in breast cancer cells: role of hypoxia-inducible factor-1alpha. Oncogene 27: 540-547. doi:10.1038/sj.onc.1210660. PubMed: 17653093.
43. Gonzalez RR, Cherfils S, Escobar M, Yoo JH, Carino C, et al. (2006) Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2). J Biol Chem 281: 26320-26328. doi:10.1074/jbc.M601991200. PubMed: 16825198.
44. Balaiya S, Khetpal V, Chalam KV, (2012) Hypoxia initiates sirtuin1-mediated vascular endothelial growth factor activation in choroidal endothelial cells through hypoxia inducible factor-2alpha. Mol Vis 18: 114-120. PubMed: 22275802.
45. Dong X, Wang YS, Dou GR, Hou HY, Shi YY, et al. (2011) Influence of Dll4 via HIF-1alpha-VEGF signaling on the angiogenesis of choroidal neovascularization under hypoxic conditions. PLOS ONE 6: e18481. doi:10.1371/journal.pone.0018481. PubMed: 21526177.
46. Huang L, Yu W, Li X, Xu Y, Niu L, et al. (2009) Expression of Robo4 in the fibrovascular membranes from patients with proliferative diabetic retinopathy and its role in RF/6A and RPE cells. Mol Vis 15: 1057-1069. PubMed: 19495426.
47. Ottino P, Finley J, Rojo E, Ottlecz A, Lambrou GN, et al. (2004) Hypoxia activates matrix metalloproteinase expression and the VEGF system in monkey choroid-retinal endothelial cells: Involvement of cytosolic phospholipase A2 activity. Mol Vis 10: 341-350. PubMed: 15162095.
48. Xu Y, Zhao H, Zheng Y, Gu Q, Ma J, et al. (2010) A novel antiangiogenic peptide derived from hepatocyte growth factor inhibits neovascularization in vitro and in vivo. Mol Vis 16: 1982-1995. PubMed: 21031024.
49. Rusovici R, Sakhalkar M, Chalam KV, (2011) Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cells. Mol Vis 17: 3339-3346. PubMed: 22219629.
50. Rusovici R, Patel CJ, Chalam KV, (2013) Bevacizumab inhibits proliferation of choroidal endothelial cells by regulation of the cell cycle. Clin. Ophthalmologe 7: 321-327.
51. Artwohl M, Roden M, Hölzenbein T, Freudenthaler A, Waldhäusl W, et al. (2002) Modulation by leptin of proliferation and apoptosis in vascular endothelial cells. Int J Obes Relat Metab Disord 26: 577-580. doi:10.1038/sj.ijo.0801947. PubMed: 12075587.
52. Oda A, Taniguchi T, Yokoyama M, (2001) Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci 47: 141-150. PubMed: 11729375.
53. Gonzalez-Perez RR, Xu Y, Guo S, Watters A, Zhou W, et al. (2010) Leptin upregulates VEGF in breast cancer via canonic and non-canonical signalling pathways and NFkappaB/HIF-1alpha activation. Cell Signal 22: 1350-1362. doi:10.1016/j.cellsig.2010.05.003. PubMed: 20466060.
54. Rouet-Benzineb P, Aparicio T, Guilmeau S, Pouzet C, Descatoire V, et al. (2004) Leptin counteracts sodium butyrate-induced apoptosis in human colon cancer HT-29 cells via NF-kappaB signaling. J Biol Chem 279: 16495-16502. doi:10.1074/jbc.M312999200. PubMed: 14752104.
55. Yeh WL, Lu DY, Lee MJ, Fu WM, (2009) Leptin induces migration and invasion of glioma cells through MMP-13 production. Glia 57: 454-464. doi:10.1002/glia.20773. PubMed: 18814267.
56. Lukiw WJ, Ottlecz A, Lambrou G, Grueninger M, Finley J, et al. (2003) Coordinate activation of HIF-1 and NF-kappaB DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia. Invest Ophthalmol Vis Sci 44: 4163-4170. doi:10.1167/iovs.02-0655. PubMed: 14507857.
57. Nelson DE, Ihekwaba AE, Elliott M, Johnson JR, Gibney CA, et al. (2004) Oscillations in NF-kappaB signaling control the dynamics of gene expression. Science 306: 704-708. doi:10.1126/science.1099962. PubMed: 15499023.
58. Ricker LJ, Kijlstra A, Kessels AG, de Jager W, Hendrikse F, et al. (2012) Adipokine levels in subretinal fluid from patients with rhegmatogenous retinal detachment. Exp Eye Res 94: 56-62. doi:10.1016/j.exer.2011.11.006. PubMed: 22138416.